Notification of Transactions of
Directors and Persons Discharging Managerial Responsibility
Vesting of conditional share awards made under
the GlaxoSmithKline Share Value Plan
This notification sets out the vesting of awards over Ordinary Shares made in 2011 under the GlaxoSmithKline Share Value Plan (SVP), which were conditional on continued employment with the GlaxoSmithKline group.
The three-year vesting period for the 2011 SVP awards, which commenced on 24 February 2011, has now ended. The vesting of the SVP awards on 24 February 2014 made to individuals who have subsequently been appointed Persons Discharging Managerial Responsibility (PDMR), are given in the table below.
Name of PDMR |
Number of Ordinary Shares vested |
Number of ADS vested |
Mr R Connor |
8,230 |
|
Mr J Ford |
|
5,740 |
Mr P Thomson |
10,050 |
|
Mrs V Whyte |
10,050 |
|
The Company and PDMRs were advised of these transactions on 25 February 2014.
The fair market values of an Ordinary Share and of an ADS of GlaxoSmithKline plc at the point of vesting on 24 February 2014 were £16.83 and US$55.75 respectively.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
Sonja Arsenić
Corporate Secretariat
25 February 2014